Endoglin antibody (Middle Region)
Quick Overview for Endoglin antibody (Middle Region) (ABIN951149)
Target
See all Endoglin (ENG) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 272-302, Middle Region
-
Specificity
- This antibody recognizes Human CD105 / Endoglin (Center).
-
Purification
- Affinity Chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 272-302 amino acids from the Central region of Human CD105 / Endoglin. Genename: ENG
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Endoglin (ENG)
-
Alternative Name
- CD105 / Endoglin
-
Background
- This gene encodes a homodimeric transmembrane protein which is a major glycoprotein of the vascular endothelium. This protein is a component of the transforming growth factor beta receptor complex and it binds TGFB1 and TGFB3 with high affinity. Mutations in this gene cause hereditary hemorrhagic telangiectasia, also known as Osler-Rendu-Weber syndrome 1, an autosomal dominant multisystemic vascular dysplasia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.Synonyms: END, ENG, HHT1, ORW, ORW1
-
Molecular Weight
- 70578 Da
-
Gene ID
- 2022
-
NCBI Accession
- NP_000109
Target
-